Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?;Lo stress ossidativo nella sindrome metabolica e nella steatoepatite non alcolica. È possibile un ruolo delle vitamine nella pratica clinica?

Recenti Progressi in Medicina

Volumn 97, Issue 1, 2006, Pages 1-6

  Miele, Luca ^a   Gabrieli, Maria L ^a   Forgione, Alessandra ^a   Vero, Vittoria ^a   Gallo, Antonella ^a   Capristo, Esmeralda ^a   Gasbarrini, Giovanni ^a   Grieco, Antonio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Fatty liver; Metabolic syndrome; Nonalcoholic steatohepatitis; Oxidative stress; Vitamin

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL PRACTICE; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; REVIEW; ADULT; ANIMAL; CELL CULTURE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FATTY LIVER; FEMALE; HEPATITIS; MALE; METABOLISM; RAT; RISK FACTOR; TIME;

ANTIOXIDANT; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; SILIBININ; SILYMARIN; VITAMIN; VITAMIN D;

ADULT; ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; CLINICAL TRIALS; ENDOTHELIAL CELLS; FATTY LIVER; FEMALE; FOLIC ACID; HEPATITIS; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; RATS; RISK FACTORS; SILYMARIN; TIME FACTORS; VITAMIN B 12; VITAMIN D; VITAMINS;

EID: 33645319242     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Reaven GM. Role of insulin resistance in human disease. Banting lecture 1988. Diabetes 1988; 37: 1595-607.
2. Meigs JB: Epidemiology of the metabolic syndrome, 2002. Am J Manag Care 2002; 8 (suppl): S292.
3. Executive summary of the Third Report of the National Cholesterol Education program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of Hight Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
4. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003; 52: 2346-52.
5. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-5.
6. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
7. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998; 114: 842-5.
8. Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 2002; 50: 585-8.
9. Fong DG, Nehra V, Lindor KD, et al. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 2000; 32: 3-10.
10. Armuzzi A, Candelli M, Zocco MA, Andreoli A, De Lorenzo A, Nista EC, Miele L, Cremonini F, Cazzato IA, Grieco A, Gasbarrini G, Gasbarrini A. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther 2002; 16: 1377-96.
11. Miele L, Grieco A, Armuzzi A, Candelli M, Forgione A, Gasbarrini A, Gasbarrini G. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13c-octanoate breath test. Am J Gastroenterol. 2003; 98: 2335-6.
12. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2002; 282: G193-9.
13. Kern PA, Saghizadeh M, Ong JM, et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-9.
14. Vendemiale G, Grattagliano I, Altomare E. An update on the role of free radicals and antioxidant defense in human disease Int J Clin Lab Res 1999; 29: 49-55.
15. Grieco A, Armuzzi A, Miele L, Zocco MA, Pignataro G, Marcoccia S, Gasbarrini GB, Gasbarrini A. 13C-Methacetin Breath Test in patients with nonalcoholic steatohepatitis. Gastroenterology 2000; 118, supplement 2.
16. Miele L, Grieco A, Armuzzi A, Capristo E, Di Rocco P, Zocco MA, Alfei B, Forgione A, Gasbarrini G, Gasbarrini A. 13C-Methacetin Breath Test in patients with nonalcoholic steatohepatitis after hypocaloric diet therapy. J Hepatol 2001; 34 (suppl 1): 198.
17. Harrison SA, Diehl AM. Fat and the liver-a molecular overview. Semin Gastrointest Dis 2002; 13: 3-16.
18. Pessayre D, Berson A, Fromenty B, et al. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57-69.
19. Rao MS, Reddy JK. Peroxisomal β-oxidation and steatohepatitis. Semin Liver Dis 2001; 21: 43-55.
20. Setola E, Monti LD, Galluccio E, Palloshi A, Fragasso G, Paroni R, Magni F, Sandoli EP, Lucotti P, Costa S, Fermo I, Galli-Kienle M, Origgi A, Margonato A, Piatti P. Insulin resistance and endothelial function are improved after Mate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 2004; 151: 483-9.
21. Trappoliere M, Tuccillo C, Federico A, Di Leva A, et al. The treatment of NAFLD. Eur Rev Med Pharmacol Sci 2005; 9: 299-304.
22. Holven KB, Haugstad TS, Holm T, Aukrust P, Ose L, Nenseter MS. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects. Br J Nutr 2003; 89: 359-63.
23. Sydow K, Schwedhelm E, Arakawa N, Bode-Boger SM, Tsikas D, Hornig B, Frolich JC, Boger RH. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovasc Res 2003; 57: 244-52.
24. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-5.
25. Pereira MA, Jacobs DRJ, Van Horn L, et al. Dairy comsumption, obesity and the insulin resistence syndrome in young adults. The CARDIA Study. JAMA 2002; 287: 2081-9.